Physician profile
Leann D Moore
NPI 1659327864
$4,264.98
in general payments reported to CMS, 2019-2025
34 companies · $27.51 in 2025
The $27.51 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,696 · 2020: $1,379 · 2021: $1,162 · 2025: $27.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $493.60 | 2019-2021 | |
| Novo Nordisk INC | $481.17 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $407.52 | 2019-2021 | |
| Glaxosmithkline, LLC. | $326.99 | 2019-2021 | |
| Amarin Pharma, INC. | $300.00 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $253.08 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $249.15 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.08 | 2019-2021 | |
| Pfizer INC. | $194.66 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $189.71 | 2019-2021 | |
| Lilly USA, LLC | $160.42 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $135.94 | 2019-2021 | |
| Hikma Pharmaceuticals USA | $102.42 | 2019-2021 | |
| Eisai INC. | $101.22 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $77.31 | 2019-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $76.46 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $64.07 | 2019-2021 | |
| Abbvie INC. | $59.92 | 2020-2021 | |
| Esperion Therapeutics, INC. | $51.31 | 2021 | |
| Boston Scientific Corporation | $45.82 | 2019-2020 | |
| Mylan Specialty L.P. | $39.99 | 2021 | |
| Emd Serono, INC. | $27.51 | 2025 | |
| Allergan, INC. | $26.51 | 2019-2020 | |
| Daiichi Sankyo INC. | $20.70 | 2020 | |
| Shire North American Group INC | $20.64 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.22 | 2019 | |
| Abbott Laboratories | $16.00 | 2021 | |
| Nalpropion Pharmaceuticals LLC | $15.95 | 2019 | |
| Antares Pharma, INC. | $15.67 | 2021 | |
| Currax Pharmaceuticals LLC | $14.79 | 2020 | |
| Philips North America LLC | $14.36 | 2020 | |
| Sunovion Pharmaceuticals INC. | $12.85 | 2020 | |
| Astellas Pharma US INC | $12.00 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.94 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leann Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.